You are here

Home

Clinical Trials: Kidney Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, September 13, 2021 - 12:00
Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease
Conditions:   Chronic Kidney Disease Stage 3B;   Chronic Kidney Disease stage4
Intervention:   Biological: Cellgram-CKD
Sponsor:   Pharmicell Co., Ltd.
Not yet recruiting
Posted: Monday, August 30, 2021 - 12:00
Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)
Condition:   Osteoarthritis, Knee
Interventions:   Drug: Bone marrow mesenchymal stem cells;   Drug: hyaluronic acid
Sponsors:   Taiwan Bio Therapeutics Co., Ltd.;   A2 Healthcare Taiwan Corporation
Not yet recruiting
Posted: Tuesday, August 24, 2021 - 12:00
STUDY OF RENAL AUTOLOGOUS CELL THERAPY (REACT) IN SUBJECTS WITH TYPE 1 or 2 DIABETES AND CHRONIC KIDNEY DISEASE (REGEN-007)
Condition:   Chronic Kidney Diseases
Intervention:   Drug: Renal Autologous Cell Therapy (REACT)
Sponsor:   Prokidney
Recruiting
Posted: Tuesday, August 24, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD
Condition:   Chronic Kidney Diseases
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Thursday, May 6, 2021 - 12:00
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)
Conditions:   Ciliopathies;   Nephronophthisis;   Senior-Loken Syndrome;   Joubert Syndrome;   Jeune Syndrome;   Bardet-Biedl Syndrome
Interventions:   Other: Blood sample;   Other: Urine sample
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Tuesday, March 9, 2021 - 12:00
lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD
Conditions:   CKD;   PAD
Intervention:   Dietary Supplement: Active bamboo charcoal± probiotics
Sponsor:   National Taiwan University Hospital
Recruiting
Posted: Thursday, February 25, 2021 - 12:00
Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine
Condition:   Chronic Kidney Allograft Nephropathy
Intervention:   Drug: Valsartan 80Mg Oral Tablet
Sponsor:   Josep M Cruzado
Recruiting
Posted: Monday, October 19, 2020 - 12:00
Stem Cells for Uremic Calciphylaxis Patients
Conditions:   Chronic Kidney Diseases;   Calciphylaxis;   Calcific Uremic Arteriolopathy;   Treatment
Intervention:   Other: Human amniotic mesenchymal stem cells
Sponsor:   Ningning Wang
Recruiting
Posted: Thursday, September 24, 2020 - 12:00
Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy
Condition:   Diabetic Nephropathy
Interventions:   Drug: UC-MSCs;   Drug: Placebo
Sponsors:   Renmin Hospital of Wuhan University;   Wuhan Hamilton Biotechnology Co., Ltd
Recruiting
Posted: Wednesday, June 24, 2020 - 12:00
A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy
Conditions:   COVID-19;   Acute Kidney Injury
Interventions:   Biological: SBI-101;   Device: Sham
Sponsor:   Sentien Biotechnologies, Inc.
Not yet recruiting

Pages